The FDA has approved Boston Scientifics new device for stroke patients with irregular heart rhythm known as atrial fibrillation, and will be made available to U.S. centers involved in Boston Scientific’s clinical studies and additional specialized centers,...
According to Reuters.com, “Valeant Pharmaceuticals has increased its takeover offer for Salix Pharmaceuticals to $10.96 billion in cash…bumping out Endo International Plc, the only other bidder for the maker of gastrointestinal drugs.” Salix has...
According to an article via Becker Spine, “Zimmer is selling $7.65 billion of senior notes in connection with its pending merger with Biomet.” Click here to check out key facts about the transaction: ...
Steve Gielda Principal IGNITE SELLING Steve will be one of the distinguished speakers at the 6th Annual Medical Device and Diagnostic Sales Training and Development Conference. How many years have you been in the industry? I have been supporting...
Accelerating Product Timelines, Budgeting Practices Among Topics For Discussion (Chicago, IL) – Product development professionals throughout the medical device industry now have the opportunity to discuss the most recent challenges and best practices for...
